
Cabaletta Bio Inc
Updated August 2022.
100%
Employees say this is a great place to work
Company Overview
About The Company
Cabaletta Bio is focused on the discovery and development of T cell therapies for patients with B cell-mediated autoimmune diseases. Cabaletta’s therapeutic platform produces highly selective autologous Chimeric AutoAntibody Receptor (CAAR) T cells that are designed to precisely bind and destroy only specific autoantibody-producing B cells while sparing normal antibody-producing B cells, which are essential for human health.
Cabaletta Bio seeks to employ its specifically targeted CAAR (Chimeric AutoAntibody Receptor) T cell products to transform the lives of patients with autoimmune diseases by aiming to deliver deep and durable – potentially curative – responses.
COMPANY SIZE
57 U.S.-based Employees
(Small)
INDUSTRY
Biotechnology & Pharmaceuticals
HQ Location
Philadelphia, PA, US
Employee Demographics
Tenure
Company Culture at Cabaletta Bio Inc
The employee experience below at Cabaletta Bio Inc, compared to a typical company.
Learn More100% of employees at Cabaletta Bio Inc say it is a great place to work compared to 57% of employees at a typical U.S.-based company.
100%
Management keeps me informed about important issues and changes.
100%
Management is approachable, easy to talk with.
100%
Management is competent at running the business.
100%
Management is honest and ethical in its business practices.
100%
Our executives fully embody the best characteristics of our company.
Why Work at Cabaletta Bio Inc?
See what employees say about what makes Cabaletta Bio Inc a great workplace. These words are drawn from employee comments on the Trust Index™ survey.
Life at Cabaletta Bio Inc
Best Workplaces Lists
Great Place To Work® is proud to recognize Cabaletta Bio Inc
Don't See Your Company Listed?
Nominate your company today to join Certification Nation

CONNECT